Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis

Chandan Kumar-Sinha, Kathleen Woods Ignatoski, Marc E Lippman, Stephen P. Ethier, Arul M. Chinnaiyan

Research output: Contribution to journalArticle

177 Citations (Scopus)

Abstract

HER2 (erbB2/neu) is a member of the erbB family of receptor tyrosine kinases and is involved in regulating the growth of several types of human carcinomas. HER2 represents a successful therapeutic target of the biotechnology era as exemplified by the drug Herceptin (trastuzumab), which has clinical activity in a subset of breast cancer patients. Using DNA microarrays, we identified a cohort of genes that are differentially regulated by HER2 in breast epithelial cells. One of the HER2-regulated genes discovered was fatty acid synthase (FAS), which has been shown to be overexpressed in breast cancer as well as other cancers. FAS is implicated in tumorigenesis through its role in cell proliferation and membrane lipid incorporation of neoplastic cells. Here, we demonstrate that HER2-mediated induction of FAS is inhibitable by Herceptin and tyrosine kinase inhibitors of HER2. Through a phosphatidylinositol 3′-kinase-dependent pathway, HER2 stimulates the FAS promoter and ultimately mediates increased fatty acid synthesis. Interestingly, pharmacological inhibition of FAS preferentially induced apoptosis of HER2-overexpressing breast epithelial cells relative to matched vector control cells. These studies characterize a molecular connection between two genes individually implicated in tumorigenesis but never linked together.

Original languageEnglish
Pages (from-to)132-139
Number of pages8
JournalCancer Research
Volume63
Issue number1
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Fatty Acid Synthases
Gene Expression Profiling
Fatty Acids
Protein-Tyrosine Kinases
Carcinogenesis
Breast
Epithelial Cells
Phosphatidylinositol 3-Kinase
Breast Neoplasms
erbB-2 Genes
Membrane Lipids
Biotechnology
Oligonucleotide Array Sequence Analysis
Genes
Cell Proliferation
Pharmacology
Apoptosis
Carcinoma
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kumar-Sinha, C., Ignatoski, K. W., Lippman, M. E., Ethier, S. P., & Chinnaiyan, A. M. (2003). Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Research, 63(1), 132-139.

Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. / Kumar-Sinha, Chandan; Ignatoski, Kathleen Woods; Lippman, Marc E; Ethier, Stephen P.; Chinnaiyan, Arul M.

In: Cancer Research, Vol. 63, No. 1, 01.01.2003, p. 132-139.

Research output: Contribution to journalArticle

Kumar-Sinha, C, Ignatoski, KW, Lippman, ME, Ethier, SP & Chinnaiyan, AM 2003, 'Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis', Cancer Research, vol. 63, no. 1, pp. 132-139.
Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Research. 2003 Jan 1;63(1):132-139.
Kumar-Sinha, Chandan ; Ignatoski, Kathleen Woods ; Lippman, Marc E ; Ethier, Stephen P. ; Chinnaiyan, Arul M. / Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. In: Cancer Research. 2003 ; Vol. 63, No. 1. pp. 132-139.
@article{b9931696d8944ad1999d93e9c0c6c03c,
title = "Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis",
abstract = "HER2 (erbB2/neu) is a member of the erbB family of receptor tyrosine kinases and is involved in regulating the growth of several types of human carcinomas. HER2 represents a successful therapeutic target of the biotechnology era as exemplified by the drug Herceptin (trastuzumab), which has clinical activity in a subset of breast cancer patients. Using DNA microarrays, we identified a cohort of genes that are differentially regulated by HER2 in breast epithelial cells. One of the HER2-regulated genes discovered was fatty acid synthase (FAS), which has been shown to be overexpressed in breast cancer as well as other cancers. FAS is implicated in tumorigenesis through its role in cell proliferation and membrane lipid incorporation of neoplastic cells. Here, we demonstrate that HER2-mediated induction of FAS is inhibitable by Herceptin and tyrosine kinase inhibitors of HER2. Through a phosphatidylinositol 3′-kinase-dependent pathway, HER2 stimulates the FAS promoter and ultimately mediates increased fatty acid synthesis. Interestingly, pharmacological inhibition of FAS preferentially induced apoptosis of HER2-overexpressing breast epithelial cells relative to matched vector control cells. These studies characterize a molecular connection between two genes individually implicated in tumorigenesis but never linked together.",
author = "Chandan Kumar-Sinha and Ignatoski, {Kathleen Woods} and Lippman, {Marc E} and Ethier, {Stephen P.} and Chinnaiyan, {Arul M.}",
year = "2003",
month = "1",
day = "1",
language = "English",
volume = "63",
pages = "132--139",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis

AU - Kumar-Sinha, Chandan

AU - Ignatoski, Kathleen Woods

AU - Lippman, Marc E

AU - Ethier, Stephen P.

AU - Chinnaiyan, Arul M.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - HER2 (erbB2/neu) is a member of the erbB family of receptor tyrosine kinases and is involved in regulating the growth of several types of human carcinomas. HER2 represents a successful therapeutic target of the biotechnology era as exemplified by the drug Herceptin (trastuzumab), which has clinical activity in a subset of breast cancer patients. Using DNA microarrays, we identified a cohort of genes that are differentially regulated by HER2 in breast epithelial cells. One of the HER2-regulated genes discovered was fatty acid synthase (FAS), which has been shown to be overexpressed in breast cancer as well as other cancers. FAS is implicated in tumorigenesis through its role in cell proliferation and membrane lipid incorporation of neoplastic cells. Here, we demonstrate that HER2-mediated induction of FAS is inhibitable by Herceptin and tyrosine kinase inhibitors of HER2. Through a phosphatidylinositol 3′-kinase-dependent pathway, HER2 stimulates the FAS promoter and ultimately mediates increased fatty acid synthesis. Interestingly, pharmacological inhibition of FAS preferentially induced apoptosis of HER2-overexpressing breast epithelial cells relative to matched vector control cells. These studies characterize a molecular connection between two genes individually implicated in tumorigenesis but never linked together.

AB - HER2 (erbB2/neu) is a member of the erbB family of receptor tyrosine kinases and is involved in regulating the growth of several types of human carcinomas. HER2 represents a successful therapeutic target of the biotechnology era as exemplified by the drug Herceptin (trastuzumab), which has clinical activity in a subset of breast cancer patients. Using DNA microarrays, we identified a cohort of genes that are differentially regulated by HER2 in breast epithelial cells. One of the HER2-regulated genes discovered was fatty acid synthase (FAS), which has been shown to be overexpressed in breast cancer as well as other cancers. FAS is implicated in tumorigenesis through its role in cell proliferation and membrane lipid incorporation of neoplastic cells. Here, we demonstrate that HER2-mediated induction of FAS is inhibitable by Herceptin and tyrosine kinase inhibitors of HER2. Through a phosphatidylinositol 3′-kinase-dependent pathway, HER2 stimulates the FAS promoter and ultimately mediates increased fatty acid synthesis. Interestingly, pharmacological inhibition of FAS preferentially induced apoptosis of HER2-overexpressing breast epithelial cells relative to matched vector control cells. These studies characterize a molecular connection between two genes individually implicated in tumorigenesis but never linked together.

UR - http://www.scopus.com/inward/record.url?scp=0037226462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037226462&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 132

EP - 139

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 1

ER -